Paragon 28 is Colorado-based medical device company focused exclusively on the foot and ankle orthopedic segment. Zimmer Biomet (ZBH) will pay $13.00 per share in cash for Paragon 28 (FNA), which ...

Piper Sandler & Co is to provide exclusive financial advisory services for Paragon 28 while Cravath, Swaine & Moore will act as its legal advisers. Last month, Zimmer Biomet received 510(k ...

With the $1.1 billion acquisition, Zimmer Biomet expects its sports medicine, extremities and trauma segment will outpace ...

During the last three months, 5 analysts shared their evaluations of Paragon 28 (NYSE:FNA), revealing diverse outlooks from bullish to bearish. The table below offers a condensed view of their ...

Since its inception, Paragon 28 has been singularly focused on bringing to market innovative solutions to address areas of unmet need in the foot and ankle segment. Strengthens and expands ...

JPMorgan Chase & Co. raised its position in Paragon 28 by 2,141.7% during the third quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock valued at $5,243,000 after ...

JPMorgan Chase & Co. lifted its position in Paragon 28 by 2,141.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 784,878 shares of the company’s stock valued at $5,243,000 after acquiring an ...

Jan 28 (Reuters) - Zimmer Biomet (ZBH.N), opens new tab said on Tuesday it would acquire medical device company Paragon 28 (FNA.N), opens new tab for about $1.1 billion to expand its portfolio of ...

Zimmer Biomet to acquire Paragon 28 for $13/share, totaling $1.2B in enterprise value. Deal expected to close in H1 2025, with potential $1/share CVR based on 2026 sales milestones. Get real-time ...

Expected to Enhance Zimmer Biomet's Financial Profile; Immediately Accretive to Revenue Growth and Accretive to Adjusted EPS within 24 Months of Deal Close WARSAW, Ind. and ENGLEWOOD, Colo.